Researcher

Title

• Full Professor of Clinic, Department of Pediatrics, Université de Montréal (2020)
• Secondary affiliation at the School of Public Health of the Université de Montréal
• Researcher, Centre de recherche Azrieli du CHU Sainte-Justine (2008).

• PhD, Institute for Public Health Genetics, University of Washington, 2008.
• Masters in Public Health, Institute for Public Health Genetics, University of Washington, 2005.
• Fellow in Medical Genetics, Royal College of Physicians and Surgeons of Canada, 2003.
• Specialization in Medical Genetics, University of Montreal, 2003.
• MD, University of Montreal, 1998.

• Clinical use of new technologies
• Population-based genetic screening
• Implications and utility of accidental or secondary findings of genetic testing
• Genetic diseases and organisation of genetics services in Québec and Canada
• Ethical, economical, legal and social issues in genetics
• Public health and genetics

Awards and Distinctions

• "Chercheur Boursier Clinicien Senior" Award, Fonds de recherche du Québec – Santé (2021-2025)
• "Chercheur Boursier Clinicien Junior 2" Award, Fonds de recherche du Québec – Santé (2019-2021)
• "Chercheur Boursier Clinicien Junior 1" Award, Fonds de recherche du Québec – Santé (2013-2017)
• Initiative stratégique de l’Institut de Génétique des IRSC, Salary award for clinical researcher in medical genetics (2009-2011, 2011-2013)

Presentations

• 2024. Données incidentes (Trouvailles fortuites) : faire ou ne pas faire. La perspective du Québec. Troisième édition des Rencontres Science Humaines et Sociales et Médecine génomique. Toulouse, France (Virtuel).
• 2024. Beyond diagnostic yield: clinical and ethical implications of implementation of genomic technologies in practice. TeleGRAF (webinaire pancanadien mensuel pour médecins généticiens et residents en génétique médicale). Montréal, QC (Virtuel)
• 2024. Controversies Surrounding Utility of Genetic Testing. Joint International Conference on Clinical Ethics and Consultation/Annual Conference of the Canadian Bioethics Society. Montréal, QC.
• 2023. Meilleures pratiques pour le consentement des patients en génomique clinique et pour la gestion des découvertes fortuites. Rendez-vous Génome Québec – Médecine Génomique. Montréal, Québec

Publications

1. Azuelos C, Marquis MA, Laberge AM. A systematic review of the assessment of the clinical utility of genomic sequencing: Implications of the lack of standard definitions and measures of clinical utility. Eur J Med Genet. 2024 Apr;68:104925. doi: 10.1016/j.ejmg.2024.104925. Epub 2024 Mar 1. PMID: 38432472.
2. Coulombe F, Laberge AM. The Need to Consider Context: A Systematic Review of Factors Involved in the Consent Process for Genetic Tests from the Perspective of Patients. AJOB Empir Bioeth. 2024 Apr-Jun;15(2):93-107. doi: 10.1080/23294515.2023.2297935. Epub 2024 Jan 8. PMID: 38189769.
3. Laberge AM. From Community-Based Carrier Programs to Opportunistic Carrier Screening: How the Objective of Carrier Screening Was Lost in Translation. Am J Bioeth. 2023 Jul;23(7):123-126. doi: 10.1080/15265161.2023.2207520. PMID: 37339295.
4. Laberge AM, Roy MC, Kleiderman E, Ravitsky V. Going Back to Basics: What is the Target of Prenatal Screening? Am J Bioeth. 2023 Mar;23(3):50-52. doi: 10.1080/15265161.2023.2169400. PMID: 36919551.
5. Lazier J, Hartley T, Brock JA, Caluseriu O, Chitayat D, Laberge AM, Langlois S, Lauzon J, Nelson TN, Parboosingh J, Stavropoulos DJ, Boycott K, Armour CM; Canadian College of Medical Geneticists. Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists. J Med Genet. 2022 Oct;59(10):931-937. doi: 10.1136/jmedgenet-2021-107897. Epub 2021 Sep 20. PMID: 34544840; PMCID: PMC9554053
6. Morel-Laforce T, Ravitsky V, Laberge AM. La recherche translationnelle et la science de l’implantation : des outils pour les bioéthiciens pour étudier les enjeux éthiques de nouvelles technologies. Canadian Journal of Bioethics / Revue canadienne de bioéthique Volume 5, numéro 2, 2022, p. 88–99.
7. Ravitsky V, Birko S, Le Clerc-Blain J, Haidar H, Affdal AO, Lemoine MÈ, Dupras C, Laberge AM. Noninvasive Prenatal Testing: Views of Canadian Pregnant Women and Their Partners Regarding Pressure and Societal Concerns. AJOB Empir Bioeth. 2021 Jan-Mar;12(1):53-62. doi: 10.1080/23294515.2020.1829173. Epub 2020 Oct 23. PMID: 33095108.
8. Votova K, Laberge AM, Grimshaw JM, Wilson B. Implementation science as a leadership capability to improve patient outcomes and value in healthcare. Healthc Manage Forum. 2019 Aug 25:840470419867427. doi: 10.1177/0840470419867427.
9. Laberge AM, Birko S, Lemoine MÈ, Le Clerc-Blain J, Haidar H, Affdal AO, Dupras C, Ravitsky V. Canadian Pregnant Women's Preferences Regarding NIPT for Down Syndrome: The Information They Want, How They Want to Get It, and With Whom They Want to Discuss It. J Obstet Gynaecol Can. 2019 Jun;41(6):782-791. doi: 10.1016/j.jogc.2018.11.003. Epub 2019 Feb 7. PubMed PMID: 30738740
10. Tremblay I, Janvier A, Laberge AM. Paediatricians underuse recommended genetic tests in children with global developmental delay. Paediatr Child Health. 2018 Dec;23(8):e156-e162. doi: 10.1093/pch/pxy033. Epub 2018 Apr 5. PubMed PMID: 30842697; PubMed Central PMCID: PMC6241916.